Evidence map›Paper›PMID 18606910›Full record

ArticleHypertension (Dallas, Tex. : 1979)2008

Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat.

Frank A DeLano, Geert W Schmid-Schönbein

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01375491 (Blockade of Receptor Cleavage in Diabetes Mellitus With an MMP Inhibitor), which is not on this map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01375491 phase4completednot on this mapstarted 2009, after this paper: background citation

Blockade of Receptor Cleavage in Diabetes Mellitus With an MMP Inhibitor

TypeinterventionalSponsorUniversity of California, San DiegoRan2009 to 2011Enrolled39ConditionsType 2 Diabetes, ObesityArmsDoxycycline, Placebo
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Aging by autodigestion.PloS one · 2024
    Article
  3. Article
  4. Article
  5. Molecular Interactions of Arterial Hypertension in Its Target Organs.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Neutrophil Modulation in Alpha-1 Antitrypsin Deficiency.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. IGF-1 receptor cleavage in hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2018
    Article
  15. Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.Advances in pharmacology (San Diego, Calif.) · 2018
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Frank A DeLanoDepartment of Bioengineering, Whitaker Institute for Biomedical Engineering, University of California San Diego, La Jolla CA 92093-0412, USA.
Geert W Schmid-Schönbein
La Jolla Bioengineering Institute · US

Funding

STRUCTURE/FUNCTION OF THE MICROCIRCULATIOMR01HL010881 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHMID-SCHOENBEIN, GEERT W. · 1985 to 2011
$3.1M
NHLBI NIH HHS HL-10881NHLBI NIH HHS R01 HL010881
6 · The paper itself

Abstract

Arterial hypertension is associated with organ dysfunctions, but the mechanisms are uncertain. We hypothesized that enhanced proteolytic activity in the microcirculation of spontaneously hypertensive rats (SHRs) may be a pathophysiological mechanism causing cell membrane receptor cleavage and examine this for 2 different receptors. Immunohistochemistry of matrix-degrading metalloproteinases (matrix metalloproteinase [MMP]-9) protein shows enhanced levels in SHR microvessels, mast cells, and leukocytes compared with normotensive Wistar-Kyoto rats. In vivo microzymography shows cleavage by MMP-1 and -9 in SHRs that colocalizes with MMP-9 and is blocked by metal chelation. SHR plasma also has enhanced protease activity. We demonstrate with an antibody against the extracellular domain that the insulin receptor-alpha density is reduced in SHRs, in line with elevated blood glucose levels and glycohemoglobin. There is also cleavage of the binding domain of the leukocyte integrin receptor CD18 in line with previously reported reduced leukocyte adhesion. Blockade of MMPs with a broad-acting inhibitor (doxycycline, 5.4 mg/kg per day) reduces protease activity in plasma and microvessels; blocks the proteolytic cleavage of the insulin receptor, the reduced glucose transport; normalizes blood glucose levels and glycohemoglobin levels; and reduces blood pressure and enhanced microvascular oxidative stress of SHRs. The results suggest that elevated MMP activity leads to proteolytic cleavage of membrane receptors in the SHR, eg, cleavage of the insulin receptor-binding domain associated with insulin resistance.

Indexed as

Insulin ResistanceAnalysis of VarianceAnimalsBlood GlucoseBlood Pressure DeterminationDisease Models, AnimalHemodynamicsHypertensionLeukocyte CountMaleMatrix Metalloproteinase 9Matrix MetalloproteinasesMicrocirculationMyeloblastinProbabilityRandom AllocationBlood GlucoseMatrix Metalloproteinase 9Matrix MetalloproteinasesMyeloblastinReceptor, Insulin

Identifiers

PMID18606910
PMCPMC2677556
OpenAlexW2128877620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.